{"id":"https://openalex.org/W2029839739","doi":"https://doi.org/10.1021/js980072c","title":"Design and Development of Adjuvant-Active Nonionic Block Copolymers","display_name":"Design and Development of Adjuvant-Active Nonionic Block Copolymers","publication_year":1998,"publication_date":"1998-11-01","ids":{"openalex":"https://openalex.org/W2029839739","doi":"https://doi.org/10.1021/js980072c","mag":"2029839739","pmid":"https://pubmed.ncbi.nlm.nih.gov/9811490"},"language":"en","primary_location":{"id":"doi:10.1021/js980072c","doi":"https://doi.org/10.1021/js980072c","is_oa":false,"landing_page_url":"https://doi.org/10.1021/js980072c","pdf_url":null,"source":{"id":"https://openalex.org/S130661733","display_name":"Journal of Pharmaceutical Sciences","issn_l":"0022-3549","issn":["0022-3549","1520-6017"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmaceutical Sciences","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5088019995","display_name":"Mark J. Newman","orcid":"https://orcid.org/0000-0002-0433-6690","observed_orcids":["https://orcid.org/0000-0002-0433-6690"]},"institutions":[{"id":"https://openalex.org/I4210102690","display_name":"Vaxcel (United States)","ror":"https://ror.org/0198hft79","country_code":"US","type":"company","lineage":["https://openalex.org/I4210102690"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Mark J. Newman","raw_affiliation_strings":["Vaxcel, Inc., 154 Technology Parkway, Norcross, Georgia 30092 and CytRx Corporation, 154 Technology Parkway, Norcross, Georgia 30092, USA. newmanm@cytrx.com","Vaxcel, Inc., 154 Technology Parkway, Norcross, Georgia 30092"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vaxcel, Inc., 154 Technology Parkway, Norcross, Georgia 30092 and CytRx Corporation, 154 Technology Parkway, Norcross, Georgia 30092, USA. newmanm@cytrx.com","institution_ids":[]},{"raw_affiliation_string":"Vaxcel, Inc., 154 Technology Parkway, Norcross, Georgia 30092","institution_ids":["https://openalex.org/I4210102690"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108451407","display_name":"Charles W. Todd","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210102690","display_name":"Vaxcel (United States)","ror":"https://ror.org/0198hft79","country_code":"US","type":"company","lineage":["https://openalex.org/I4210102690"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charles W. Todd","raw_affiliation_strings":["Vaxcel, Inc., 154 Technology Parkway, Norcross, Georgia 30092"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vaxcel, Inc., 154 Technology Parkway, Norcross, Georgia 30092","institution_ids":["https://openalex.org/I4210102690"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5058898568","display_name":"Mannersamy Balusubramanian","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I909123340","display_name":"CytRx (United States)","ror":"https://ror.org/02m8d5f73","country_code":"US","type":"company","lineage":["https://openalex.org/I909123340"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mannersamy Balusubramanian","raw_affiliation_strings":["CytRx Corporation, 154 Technology Parkway, Norcross, Georgia 30092"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CytRx Corporation, 154 Technology Parkway, Norcross, Georgia 30092","institution_ids":["https://openalex.org/I909123340"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5088019995"],"corresponding_institution_ids":["https://openalex.org/I4210102690"],"apc_list":{"value":3620,"currency":"USD","value_usd":3620},"apc_paid":null,"fwci":0.1172,"has_fulltext":false,"cited_by_count":14,"citation_normalized_percentile":{"value":0.43831169,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"87","issue":"11","first_page":"1357","last_page":"1362"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.8647000193595886,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.8647000193595886,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10405","display_name":"Advanced Polymer Synthesis and Characterization","score":0.057999998331069946,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10721","display_name":"Surfactants and Colloidal Systems","score":0.03359999880194664,"subfield":{"id":"https://openalex.org/subfields/1606","display_name":"Physical and Theoretical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nonionic-block-copolymers","display_name":"nonionic block copolymers","score":0.9950000047683716},{"id":"https://openalex.org/keywords/vaccine-adjuvants","display_name":"vaccine adjuvants","score":0.9810000061988831},{"id":"https://openalex.org/keywords/poly-ethylene-oxide","display_name":"poly(ethylene oxide)","score":0.9950000047683716},{"id":"https://openalex.org/keywords/micelles","display_name":"micelles","score":0.4970000088214874},{"id":"https://openalex.org/keywords/microparticles","display_name":"microparticles","score":0.9290000200271606},{"id":"https://openalex.org/keywords/adjuvant-effect","display_name":"adjuvant effect","score":0.5929999947547913},{"id":"https://openalex.org/keywords/copolymer-molecular-weight","display_name":"copolymer molecular weight","score":0.8389999866485596},{"id":"https://openalex.org/keywords/copolymer-composition","display_name":"copolymer composition","score":0.6480000019073486}],"concepts":[{"id":"https://openalex.org/C15920480","wikidata":"https://www.wikidata.org/wiki/Q421281","display_name":"Copolymer","level":3,"score":0.9469702839851379},{"id":"https://openalex.org/C2777801237","wikidata":"https://www.wikidata.org/wiki/Q407473","display_name":"Ethylene oxide","level":4,"score":0.7915960550308228},{"id":"https://openalex.org/C11268172","wikidata":"https://www.wikidata.org/wiki/Q421110","display_name":"Micelle","level":3,"score":0.7549174427986145},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.6813889741897583},{"id":"https://openalex.org/C188027245","wikidata":"https://www.wikidata.org/wiki/Q750446","display_name":"Polymer chemistry","level":1,"score":0.5728504061698914},{"id":"https://openalex.org/C2777505466","wikidata":"https://www.wikidata.org/wiki/Q727742","display_name":"Propylene oxide","level":5,"score":0.5710030794143677},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.44545602798461914},{"id":"https://openalex.org/C184651966","wikidata":"https://www.wikidata.org/wiki/Q906356","display_name":"Aqueous solution","level":2,"score":0.4349236786365509},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.422625869512558},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.18811166286468506},{"id":"https://openalex.org/C521977710","wikidata":"https://www.wikidata.org/wiki/Q81163","display_name":"Polymer","level":2,"score":0.09718337655067444},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.058317989110946655},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.0536632239818573}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004337","descriptor_name":"Drug Carriers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007252","descriptor_name":"Influenza Vaccines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D007252","descriptor_name":"Influenza Vaccines","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D008807","descriptor_name":"Mice, Inbred BALB C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008863","descriptor_name":"Microspheres","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010047","descriptor_name":"Ovalbumin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D010047","descriptor_name":"Ovalbumin","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D011095","descriptor_name":"Polyethylenes","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D011126","descriptor_name":"Polypropylenes","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D016503","descriptor_name":"Drug Delivery Systems","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1021/js980072c","doi":"https://doi.org/10.1021/js980072c","is_oa":false,"landing_page_url":"https://doi.org/10.1021/js980072c","pdf_url":null,"source":{"id":"https://openalex.org/S130661733","display_name":"Journal of Pharmaceutical Sciences","issn_l":"0022-3549","issn":["0022-3549","1520-6017"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmaceutical Sciences","raw_type":"journal-article"},{"id":"pmid:9811490","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9811490","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of pharmaceutical sciences","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.504800021648407,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":55,"referenced_works":["https://openalex.org/W5318164","https://openalex.org/W37179351","https://openalex.org/W77869290","https://openalex.org/W136290254","https://openalex.org/W173226072","https://openalex.org/W187555657","https://openalex.org/W237758694","https://openalex.org/W371888784","https://openalex.org/W1265388268","https://openalex.org/W1502243809","https://openalex.org/W1549724320","https://openalex.org/W1564933160","https://openalex.org/W1570481990","https://openalex.org/W1619931878","https://openalex.org/W1839414573","https://openalex.org/W1877627173","https://openalex.org/W1912756766","https://openalex.org/W1915092098","https://openalex.org/W1922307675","https://openalex.org/W1935912749","https://openalex.org/W1948221318","https://openalex.org/W1979988802","https://openalex.org/W1982696173","https://openalex.org/W1991831908","https://openalex.org/W1992497253","https://openalex.org/W1994102705","https://openalex.org/W2020987313","https://openalex.org/W2023702014","https://openalex.org/W2029836713","https://openalex.org/W2039659662","https://openalex.org/W2041351975","https://openalex.org/W2053798163","https://openalex.org/W2069929345","https://openalex.org/W2074061180","https://openalex.org/W2075535116","https://openalex.org/W2075852670","https://openalex.org/W2080667413","https://openalex.org/W2082617147","https://openalex.org/W2128942611","https://openalex.org/W2140301468","https://openalex.org/W2150902623","https://openalex.org/W2172466148","https://openalex.org/W2318138379","https://openalex.org/W2334917739","https://openalex.org/W2344025857","https://openalex.org/W2410032787","https://openalex.org/W2414389174","https://openalex.org/W2416243557","https://openalex.org/W2419439400","https://openalex.org/W2743374715","https://openalex.org/W3025036998","https://openalex.org/W4313316442","https://openalex.org/W6603186247","https://openalex.org/W6628126850","https://openalex.org/W6714646840"],"related_works":["https://openalex.org/W2031957719","https://openalex.org/W2039659662","https://openalex.org/W1997238954","https://openalex.org/W1982696173","https://openalex.org/W2057990532","https://openalex.org/W2418282192","https://openalex.org/W1502243809","https://openalex.org/W41583731","https://openalex.org/W207737380","https://openalex.org/W2492530314"],"abstract_inverted_index":{"Nonionic":[0],"block":[1,32,98,176],"copolymers":[2,20,33,90,99,149,177],"are":[3,91],"surfactants":[4],"synthesized":[5,54],"using":[6,173],"propylene":[7],"oxide":[8],"and":[9,12,29,77,89,105,117,158],"ethylene":[10],"oxide,":[11],"they":[13],"can":[14],"be":[15,170],"designed":[16,28],"so":[17],"that":[18,178],"individual":[19],"have":[21,27],"unique":[22],"vaccine":[23],"adjuvant":[24,94],"properties.":[25],"We":[26],"produced":[30,129],"nonionic":[31,97,175],"based":[34],"on":[35],"high":[36],"molecular":[37,119],"weight":[38],"(MW),":[39],"9-15":[40],"kDA,":[41],"cores":[42],"of":[43,85,96,121,126,185],"poly(oxypropylene)":[44],"(POP)":[45],"coupled":[46],"with":[47,55,80,112,138,150],"smaller":[48],"poly(oxyethylene)":[49],"(POE)":[50],"end":[51],"blocks.":[52],"Copolymers":[53,137],"less":[56],"than":[57],"10%":[58,139],"(w/w)":[59],"POE":[60,106,114,135,140,152],"will":[61,179],"spontaneously":[62],"assemble":[63],"into":[64],"300":[65],"nm-3":[66],"microm":[67],"micelles":[68],"or":[69],"microparticles":[70,83],"in":[71],"aqueous":[72],"solutions":[73],"at":[74],"physiological":[75],"pH,":[76],"when":[78],"formulated":[79],"protein,":[81],"complex":[82],"consisting":[84],"both":[86,103,155],"the":[87,134,181],"protein":[88],"formed.":[92],"The":[93,124],"activity":[95,109],"is":[100,110,130],"influenced":[101,132],"by":[102,133,172],"size":[104,120],"content;":[107],"maximal":[108],"associated":[111],"low":[113],"content,":[115],"5-10%,":[116],"a":[118],"11-12":[122],"kDa.":[123],"type":[125],"immune":[127,186],"response":[128],"also":[131],"content.":[136],"significantly":[141],"augmented":[142,154],"Type":[143,156,159],"2":[144,160],"helper":[145,161],"T-lymphocyte":[146,162],"responses":[147],"whereas":[148],"lower":[151],"contents":[153],"1":[157],"responses.":[163,187],"This":[164],"property":[165],"allows":[166],"for":[167],"vaccines":[168],"to":[169],"\"customized\"":[171],"adjuvant-active":[174],"augment":[180],"most":[182],"appropriate":[183],"types":[184]},"counts_by_year":[{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}